The Neural Zoomer Plus Test from Vibrant Wellness has been designed to assess the reactivity to 48 neurological antigens connected to various neurologically related diseases. The analysis of the most well-studied neurological autoantibodies allow physicians to select treatment protocols by unmasking the mechanisms behind disease progression.
This test aims to reduce the prevalence of neurological conditions by providing both patients and physicians with a crucial methodology for early risk detection and primary prevention.
The optional additional genetic testing for the ApoE genotype is available with the Neural Zoomer Plus Test. The ApoE genotype has been shown to influence risk for specific neurological conditions.
By selecting this test, physicians apply the most advanced and relevant test available to evaluate the presence and risk of neurological autoimmunity.
The test represents the most comprehensive and compelling scientific data identifying autoantibodies associated with a range of neurological disorders, allowing early risk detection and prevention of neurodegeneration.
There are several symptoms associated with autoimmunity in the nervous
system: cognitive decline, memory loss, ataxia, balance problems, neuropathy, Alzheimer’s disease, multiple sclerosis, encephalitis, muscle spasms, Huntington’s disease, epilepsy, Parkinson’s disease, dementia, Myasthenia Gravis, Muscle stiffness/rigidity, optical decline, neuromyelitis optica, previous history of concussion, autism, PANDAS/ANDAS/OCD, and demyelinating diseases.
The Neural Zoomer Plus Test evaluates a comprehensive list of autoimmune markers such as antigens involved in:
The test results of the antibody levels evaluated are calculated by comparing the average intensity of the individual protein antibody of each protein in a healthy reference population of 192 individuals.
This is a serum based test and requires phlebotomy. This test cannot be ordered for patients under 2 years of age.
The Neural Zoomer Plus expands upon the Neural Zoomer to assess an individual’s reactivity to 48 neurological antigens, which may have connections to a variety of neurologically related diseases. This is the serum version of the test. It is also available as a blood spot test. This test cannot be ordered for patients under two years of age.